دورية أكاديمية

Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres.

التفاصيل البيبلوغرافية
العنوان: Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres.
المؤلفون: Smith, Stephen D., Moskowitz, Craig H., Dean, Robert, Pohlman, Brad, Sobecks, Ronald, Copelan, Edward, Andresen, Steven, Bolwell, Brian, Maragulia, Jocelyn C., Vanak, Jill M., Sweetenham, John, Moskowitz, Alison J.
المصدر: British Journal of Haematology; May2011, Vol. 153 Issue 3, p358-363, 6p, 3 Charts, 2 Graphs
مصطلحات موضوعية: HODGKIN'S disease, DISEASE relapse, PROGNOSIS, STEM cell transplantation, MULTIVARIATE analysis
مستخلص: Prior series have demonstrated that early relapsed (within 1 year) or refractory Hodgkin lymphoma (HL) is associated with poor prognosis. To determine the outcome for patients with early relapsed/refractory HL in the modern era, we combined data from two large transplant centres, Cleveland Clinic Taussig Cancer Institute (CCTCI) and Memorial Sloan-Kettering Cancer Center (MSKCC), and analysed consecutive patients transplanted for relapsed/refractory HL following induction failure or remission durations of <1 year. Two hundred and fourteen patients were analysed and the event-free survival (EFS) and overall survival (OS) at 6 years for all patients were 45% and 55%, respectively. Factors significant for prognosis in multivariate analysis were extranodal disease and bulky disease (≥5 cm). Patients with 0, 1, or 2 risk factors achieved 6 year EFS of 65%, 47%, and 24% and 6 year OS of 81%, 55%, and 27%, respectively. Patients with the sole risk factor of early relapsed/refractory disease achieved good outcomes in this large series; however the presence of bulk and/or extranodal disease significantly reduced EFS and OS. Patients with these additional risk factors are best suited for clinical trials investigating novel salvage regimens and post-transplant maintenance strategies. [ABSTRACT FROM AUTHOR]
Copyright of British Journal of Haematology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00071048
DOI:10.1111/j.1365-2141.2011.08616.x